Literature DB >> 24522622

Value of diffusion-weighted imaging in predicting parametrial invasion in stage IA2-IIA cervical cancer.

Jung Jae Park1, Chan Kyo Kim, Sung Yoon Park, Byung Kwan Park, Bohyun Kim.   

Abstract

OBJECTIVE: To investigate the value of diffusion-weighted imaging (DWI) in evaluating parametrial invasion (PMI) in stage IA2-IIA cervical cancer.
METHODS: A total of 117 patients with stage IA2-IIA cervical cancer who underwent preoperative MRI and radical hysterectomy were included in this study. Preoperative clinical variables and MRI variables were analysed and compared between the groups with and without pathologically proven PMI.
RESULTS: All variables except age were significantly different between patients with and without pathologic PMI (P < 0.05). All variables except squamous cell carcinoma (SCC) antigen were also significantly correlated with pathologic PMI on univariate analysis (P < 0.05). Multivariate analysis indicated that PMI on MRI (P < 0.001) and tumour apparent diffusion coefficient (ADC) (P = 0.029) were independent predictors of pathologic PMI. Area under the curve of PMI on MRI increased significantly from 0.793 to 0.872 when combined with tumour ADC (P = 0.002). When PMI on MRI was further stratified by tumour ADC, the false negative rate was 2.0 % (1/49).
CONCLUSION: In stage IA2-IIA cervical cancer, tumour ADC and PMI on MRI seem to be independent predictors of pathologic PMI. Combining the two predictors improved the diagnostic performance of identifying patients at low risk of pathologic PMI. KEY POINTS: • Accurate PMI prediction is essential for appropriate treatment planning • Tumour ADC appears to be an independent predictor of pathologic PMI • Adding DWI to MRI improves accuracy for identifying low-risk patients for PMI.

Entities:  

Mesh:

Year:  2014        PMID: 24522622     DOI: 10.1007/s00330-014-3109-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  30 in total

1.  Revised FIGO staging for carcinoma of the cervix.

Authors:  Sergio Pecorelli; Lucia Zigliani; Franco Odicino
Journal:  Int J Gynaecol Obstet       Date:  2009-04-01       Impact factor: 3.561

2.  Invasive cervical carcinoma: comparison of MR imaging and surgical findings.

Authors:  H Hricak; C G Lacey; L G Sandles; Y C Chang; M L Winkler; J L Stern
Journal:  Radiology       Date:  1988-03       Impact factor: 11.105

3.  Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging.

Authors:  Hyun Su Kim; Chan Kyo Kim; Byung Kwan Park; Seung Jae Huh; Bohyun Kim
Journal:  J Magn Reson Imaging       Date:  2012-09-27       Impact factor: 4.813

4.  Type II versus Type III nerve-sparing radical hysterectomy: comparison of lower urinary tract dysfunctions.

Authors:  Francesco Raspagliesi; Antonino Ditto; Rosanna Fontanelli; Flavia Zanaboni; Eugenio Solima; Gianbattista Spatti; Francesco Hanozet; Francesca Vecchione; Gabriella Rossi; Shigeki Kusamura
Journal:  Gynecol Oncol       Date:  2006-01-30       Impact factor: 5.482

5.  Carcinoma of the cervix: value of plain and gadolinium-enhanced MR imaging in assessing degree of invasiveness.

Authors:  S Sironi; F De Cobelli; G Scarfone; E Colombo; G Bolis; A Ferrari; A DelMaschio
Journal:  Radiology       Date:  1993-09       Impact factor: 11.105

Review 6.  Pearls and pitfalls in MRI of gynecologic malignancy with diffusion-weighted technique.

Authors:  Stephanie Nougaret; Sree Harsha Tirumani; Helen Addley; Himanshu Pandey; Evis Sala; Caroline Reinhold
Journal:  AJR Am J Roentgenol       Date:  2013-02       Impact factor: 3.959

Review 7.  Vesical dysfunctions after radical hysterectomy for cervical cancer: a critical review.

Authors:  Marzio Angelo Zullo; Natalina Manci; Roberto Angioli; Ludovico Muzii; Pierluigi Benedetti Panici
Journal:  Crit Rev Oncol Hematol       Date:  2003-12       Impact factor: 6.312

8.  Can parametrectomy be avoided in early cervical cancer? An algorithm for the identification of patients at low risk for parametrial involvement.

Authors:  O Gemer; R Eitan; M Gdalevich; A Mamanov; B Piura; A Rabinovich; H Levavi; B Saar-Ryss; R Halperin; S Finci; U Beller; I Bruchim; T Levy; I Ben Shachar; A Ben Arie; O Lavie
Journal:  Eur J Surg Oncol       Date:  2012-11-03       Impact factor: 4.424

Review 9.  Novel imaging techniques as response biomarkers in cervical cancer.

Authors:  Vanessa N Harry
Journal:  Gynecol Oncol       Date:  2010-02       Impact factor: 5.482

10.  Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images.

Authors:  Kate Downey; Sophie F Riches; Veronica A Morgan; Sharon L Giles; Ayoma D Attygalle; Tom E Ind; Desmond P J Barton; John H Shepherd; Nandita M deSouza
Journal:  AJR Am J Roentgenol       Date:  2013-02       Impact factor: 3.959

View more
  13 in total

1.  Comparison between readout-segmented and single-shot echo-planar imaging in the evaluation of cervical cancer staging.

Authors:  Weiliang Qian; Qian Chen; Zhongshuai Zhang; Hong Wang; Jibin Zhang; Jianming Xu
Journal:  Br J Radiol       Date:  2018-11-01       Impact factor: 3.039

2.  Reduced field-of-view diffusion-weighted MRI in patients with cervical cancer.

Authors:  Jiyoung Hwang; Seong Sook Hong; Hyun-Joo Kim; Yun-Woo Chang; Bo Da Nam; Eunsun Oh; EunJi Lee; Hwajin Cha
Journal:  Br J Radiol       Date:  2018-04-16       Impact factor: 3.039

3.  Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.

Authors:  Gigin Lin; Lan-Yan Yang; Yu-Chun Lin; Yu-Ting Huang; Feng-Yuan Liu; Chun-Chieh Wang; Hsin-Ying Lu; Hsin-Ju Chiang; Yu-Ruei Chen; Ren-Chin Wu; Koon-Kwan Ng; Ji-Hong Hong; Tzu-Chen Yen; Chyong-Huey Lai
Journal:  Eur Radiol       Date:  2018-07-26       Impact factor: 5.315

Review 4.  The value of advanced MRI techniques in the assessment of cervical cancer: a review.

Authors:  Evelyn Dappa; Tania Elger; Annette Hasenburg; Christoph Düber; Marco J Battista; Andreas M Hötker
Journal:  Insights Imaging       Date:  2017-08-21

5.  Diagnosis of Cervical Cancer With Parametrial Invasion on Whole-Tumor Dynamic Contrast-Enhanced Magnetic Resonance Imaging Combined With Whole-Lesion Texture Analysis Based on T2- Weighted Images.

Authors:  Xin-Xiang Li; Ting-Ting Lin; Bin Liu; Wei Wei
Journal:  Front Bioeng Biotechnol       Date:  2020-06-11

6.  Diagnostic Performance of MRI for Assessing Parametrial Invasion in Cervical Cancer: A Head-to-Head Comparison between Oblique and True Axial T2-Weighted Images.

Authors:  Sungmin Woo; Min Hoan Moon; Jeong Yeon Cho; Seung Hyup Kim; Sang Youn Kim
Journal:  Korean J Radiol       Date:  2019-03       Impact factor: 3.500

7.  Diagnostic significance of diffusion-weighted MRI in patients with cervical cancer: a meta-analysis.

Authors:  Bo Hou; Shi-Feng Xiang; Gen-Dong Yao; Su-Jun Yang; Yu-Fang Wang; Yi-Xin Zhang; Jun-Wei Wang
Journal:  Tumour Biol       Date:  2014-08-29

8.  Diagnostic Value of Combined Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging with Diffusion Tensor Imaging in Predicting Parametrial Infiltration in Cervical Cancer.

Authors:  Ting-Ting Lin; Xin-Xiang Li; Wei-Fu Lv; Jiang-Ning Dong; Chao Wei; Ting-Ting Wang; Chuan-Bin Wang; Ping Zhang
Journal:  Contrast Media Mol Imaging       Date:  2021-05-11       Impact factor: 3.161

Review 9.  The Complementary Role of Imaging and Tumor Biomarkerszzm321990in Gynecological Cancers: An Update of the Literature

Authors:  Emanuela Anastasi; Silvia Gigli; Laura Ballesio; Antonio Angeloni; Lucia Manganaro
Journal:  Asian Pac J Cancer Prev       Date:  2018-02-26

10.  Spatial relationship of 2-deoxy-2-[18F]-fluoro-D-glucose positron emission tomography and magnetic resonance diffusion imaging metrics in cervical cancer.

Authors:  John M Floberg; Kathryn J Fowler; Dominique Fuser; Todd A DeWees; Farrokh Dehdashti; Barry A Siegel; Richard L Wahl; Julie K Schwarz; Perry W Grigsby
Journal:  EJNMMI Res       Date:  2018-06-15       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.